SCHEMBL6469853

SCHEMBL6469853

COC(=O)c1nc(SC)[nH]c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 3/20 0.38
ERCC1 P07992 1/20 0.38
FEN1 P39748 1/20 0.38
ERCC4 Q92889 1/20 0.38
KLK7 P49862 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
HTT P42858 1/20 0.36
PKM P14618 2/20 0.36
ALDH1A1 P00352 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RHEB Q15382 1/20 0.35
RNASEH1 O60930 1/20 0.35
MAPT P10636 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10463619 0.76 NPSR1 (0.50) NPSR1L3MBTL1KDM4EERCC1FEN1
SCHEMBL12844759 0.74 KLK7 (0.40) NPSR1L3MBTL1KDM4EERCC1FEN1
SCHEMBL9482238 0.73 NPSR1 (0.47) NPSR1KDM4EERCC1FEN1ERCC4
SCHEMBL14692634 0.71 PTGS1 (0.54)
SCHEMBL14799969 0.69 PIN1 (0.51) L3MBTL1KDM4EERCC1FEN1ERCC4
SCHEMBL9031781 0.68 CSNK2A2 (0.41) KDM4EKLK7ALDH1A1RAB9AMAPT
SCHEMBL9031779 0.68 CSNK2A2 (0.41) KDM4EKLK7KDM4CALDH1A1RAB9A
SCHEMBL13174730 0.67 ERCC1 (0.70) L3MBTL1KDM4EERCC1FEN1ERCC4
SCHEMBL10333608 0.67 HSD17B10 (0.46) KLK7HTTALDH1A1RAB9ASMN1; SMN2
SCHEMBL8951086 0.67 NPSR1 (1.00) NPSR1L3MBTL1KDM4EKDM4CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005011609-A2 TRIAZOLOPURINE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME BRISTOL-MYERS SQUIBB COMPANY (US) 2005-02-10 WO disclosed
WO-2004075846-A2 PYRAZOLOPURINE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-10 WO disclosed